How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in Q2 2023?

131 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value for Q2 2023. Use the holders table for investor-level position and value details.

Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 00461U105

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock, $0.00001 par value
Total 13F shares: 71,014,841
Total 13F value: $736,442,996
Share change: -501,375
Put/Call ratio: 121%
SEC-reported price per share: $10.37
Number of holders: 131
Value change: +$5,835,766
Number of buys: 65
Number of sells: 67
Shares outstanding: 138,752,791

Security key

00461U105

Report period

Q2 2023

Institutions

131

Top holders

ACRS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2023 Previous quarter: Q1 2023 Aclaris Therapeutics, Inc. SEC filings Aclaris Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00461U105

Newer quarter: Q3 2023 Previous quarter: Q1 2023

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

WELLINGTON MANAGEMENT GRO...

Disclosed value leader

WELLINGTON MANAGEMENT GRO...

Comparable rows

15/15

Latest evidence

31 Mar 2023

13F Lead comparable stake: 5.3% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 5.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.

Comparable ownership Top 5

WELLINGTON MANAGEMENT GROUP LLP 5.3%

BlackRock Finance, Inc. 3.7%

RA CAPITAL MANAGEMENT, L.P. 3.2%

Rock Springs Capital Management LP 2.9%

Bain Capital Life Sciences Invest... 2.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	5.3%	$59,644,342 7,372,601 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	3.7%	$41,383,369 5,115,373 shares	—	31 Mar 2023
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	3.2%	$35,583,485 4,398,453 shares	—	31 Mar 2023
Rock Springs Capital Management LP	13F Company 13F	2.9%	$32,051,358 3,961,849 shares	—	31 Mar 2023
Bain Capital Life Sciences Investors, LLC	13F Company 13F	2.5%	$27,506,000 3,400,000 shares	—	31 Mar 2023
BVF INC/IL	13F Company 13F	2.4%	$27,190,013 3,360,941 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

131

71,014,841

Rows available

131

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

148

Q2 2023 holders

131

Holder diff

-17

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend